| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |